Tag: investment
-
Synthetic RNA Start-Up Gains $80M in Early Funds
A start-up company, spun off from a biomedical engineering lab at MIT, is raising $80 million for therapies made from synthetic circular RNA.
-
Gene-Editing Biotech Acquires DNA Bar Code Company
A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes.
-
Infographic – Top Venture Investor in Each State
CB Insights compiled a list of the top technology venture investors in each state and D.C., and displayed the investors on a map.
-
New Funds Backing Global Health, Early-Stage Ventures
Three new funds are financing start-up companies creating solutions for health issues in less-developed countries and early-stage life science businesses.
-
AI Cell Analysis Start-Up Raises $6M Seed Funds
A new enterprise using artificial intelligence to analyze individual cells for immune-related diagnostics and therapies is raising $6 million in seed funds.
-
AbbVie Licenses Engineered Crispr Cell Process
Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies.
-
New Venture Fund Backs Underserved, Academic Start-Ups
A new $300 million venture capital fund is underway that aims to support technology start-ups often left behind by larger mainstream investors.
-
Engineered Cell Therapy Company Issues $588M IPO
A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO.
-
Cannabidiol Drug Maker Acquired in $7.2B Deal
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal.
-
Cancer Immunotherapy Adapted for HIV
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections.